Long-Term Safety, Rollover Study of Adjunctive Everolimus in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures Who Continue to Benefit from Everolimus Treatment after Completion of EXIST-3

dc.contributor.author	Gazri, H. E.
dc.contributor.author	Yapici, Z.
dc.contributor.author	Ikeda, H.
dc.contributor.author	Belousova, E.
dc.contributor.author	Lawson, J. A.
dc.contributor.author	Fan, P. -C.
dc.contributor.author	Herbst, F.
dc.contributor.author	Ridolfi, A.
dc.date.accessioned	2021-03-03T11:27:17Z
dc.date.available	2021-03-03T11:27:17Z
dc.identifier.citation	Yapici Z., Fan P. -. , Lawson J. A. , Belousova E., Gazri H. E. , Ridolfi A., Herbst F., Ikeda H., "Long-Term Safety, Rollover Study of Adjunctive Everolimus in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures Who Continue to Benefit from Everolimus Treatment after Completion of EXIST-3", 13th European Congress on Epileptology, Vienna, Avusturya, 26 - 30 Ağustos 2018, cilt.59
dc.identifier.other	vv_1032021
dc.identifier.other	av_2802a0f5-7c5a-4ae6-8386-9eef7d271c1a
dc.identifier.uri	http://hdl.handle.net/20.500.12627/31761
dc.language.iso	eng
dc.subject	KLİNİK NEUROLOJİ
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	Nöroloji
dc.subject	Klinik Tıp
dc.title	Long-Term Safety, Rollover Study of Adjunctive Everolimus in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures Who Continue to Benefit from Everolimus Treatment after Completion of EXIST-3
dc.type	Bildiri
dc.contributor.department	Novartis , ,
dc.identifier.volume	59
dc.contributor.firstauthorID	155516

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.